| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |